A transporter interactome is essential for the acquisition of antimicrobial resistance to antibiotics

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Shuster, Yonatan ^a   Steiner Mordoch, Sonia ^a   Cudkowicz, Noemie Alon ^a   Schuldiner, Shimon ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; NORFLOXACIN; PROTEIN ACRAB; TOLC PROTEIN; UNCLASSIFIED DRUG; ACRAB-TOLC PROTEIN, E COLI; CARRIER PROTEIN; CULTURE MEDIUM; ESCHERICHIA COLI PROTEIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL; BACTERIAL SURVIVAL; BACTERIUM ISOLATE; CONTROLLED STUDY; CYTOPLASM; ESCHERICHIA COLI; NONHUMAN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; CULTURE MEDIUM; DRUG EFFECTS; METABOLISM;

CARRIER PROTEINS; CULTURE MEDIA; DRUG RESISTANCE, MICROBIAL; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS;

EID: 84963670208     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0152917     Document Type: Article

References (42)

1. Higgins CF. Multiple molecular mechanisms for multidrug resistance transporters. Nature. 2007;446(7137):749-57. PMID: 17429392
2. Saier MH Jr., Paulsen IT. Phylogeny of multidrug transporters. Semin Cell Dev Biol. 2001;12(3):205-13. PMID: 11428913
3. Nishino K, Yamaguchi A. Analysis of a complete library of putative drug transporter genes in Escherichia coli. J Bacteriol. 2001;183(20):5803-12. PMID: 11566977
4. Bush K, Courvalin P, Dantas G, Davies J, Eisenstein B, Huovinen P, et al. Tackling antibiotic resistance. Nature reviews. 2011;9(12):894-6. doi: 10.1038/nrmicro2693 PMID: 22048738
5. Carlet J, Collignon P, Goldmann D, Goossens H, Gyssens IC, Harbarth S, et al. Society's failure to protect a precious resource: antibiotics. Lancet. 2011;378(9788):369-71. doi: 10.1016/S0140-6736 (11) 60401-7 PMID: 21477855
6. Center for disease control. Antibiotics resistance threats in the USA, 2013. 2013.
7. Nikaido H, Pages JM. Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria. FEMS Microbiol Rev. 2012;36(2):340-63. doi: 10.1111/j.1574-6976.2011.00290.x PMID: 21707670
8. Nikaido H. Multidrug Resistance in Bacteria. Annu Rev Biochem. 2009;78:119-46. doi: 10.1146/annurev. biochem.78.082907.145923 PMID: 19231985
9. Blair JM, Webber MA, Baylay AJ, Ogbolu DO, Piddock LJ. Molecular mechanisms of antibiotic resistance. Nature reviews. 2015;13(1):42-51. doi: 10.1038/nrmicro3380 PMID: 25435309
10. Barbosa TM, Levy SB. Differential expression of over 60 chromosomal genes in Escherichia coli by constitutive expression of MarA. J Bacteriol. 2000;182(12):3467-74. PMID: 10852879
11. Ariza RR, Li Z, Ringstad N, Demple B. Activation of multiple antibiotic resistance and binding of stressinducible promoters by Escherichia coli Rob protein. J Bacteriol. 1995;177(7):1655-61. PMID: 7896685
12. Markham PN, Neyfakh AA. Inhibition of the multidrug transporter NorA prevents emergence of norfloxacin resistance in Staphylococcus aureus. Antimicrob Agents Chemother. 1996;40(11):2673-4. PMID: 8913490
13. Lomovskaya O, Lee A, Hoshino K, Ishida H, Mistry A, Warren MS, et al. Use of a genetic approach to evaluate the consequences of inhibition of efflux pumps in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1999;43(6):1340-6. PMID: 10348749
14. Marcusson LL, Frimodt-Moller N, Hughes D. Interplay in the selection of fluoroquinolone resistance and bacterial fitness. PLoS pathogens. 2009;5(8):e1000541. doi: 10.1371/journal.ppat.1000541 PMID: 19662169
15. Weinreich DM, Delaney NF, Depristo MA, Hartl DL. Darwinian evolution can follow only very few mutational paths to fitter proteins. Science. 2006;312(5770):111-4. PMID: 16601193
16. Chopra I, Roberts M. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev. 2001;65(2):232-60. PMID: 11381101
17. Komp Lindgren P, Karlsson A, Hughes D. Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections. Antimicrob Agents Chemother. 2003;47(10):3222-32. PMID: 14506034
18. Tal N, Schuldiner S. A coordinated network of transporters with overlapping specificities provides a robust survival strategy. Proc Natl Acad Sci USA. 2009;106(22):9051-6. doi: 10.1073/pnas. 0902400106 PMID: 19451626
19. Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M, et al. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol. 2006;2:2006-2008. PMID: 16738554
20. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA. 2000;97(12):6640-5. PMID: 10829079
21. Kallio MA, Tuimala JT, Hupponen T, Klemela P, Gentile M, Scheinin I, et al. Chipster: user-friendly analysis software for microarray and other high-throughput data. BMC genomics. 2011;12:507. doi: 10. 1186/1471-2164-12-507 PMID: 21999641
22. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C (T) method. Nat Protoc. 2008;3(6):1101-8. PMID: 18546601
23. Zayed AA, Essam TM, Hashem AG, El-Tayeb OM. 'Supermutators' found amongst highly levofloxacinresistant E. coli isolates: a rapid protocol for the detection of mutation sites. Emerging microbes & infections. 2015;4(1):e4.
24. Johnson JR, Johnston B, Kuskowski MA, Sokurenko EV, Tchesnokova V. Intensity and Mechanisms of Fluoroquinolone Resistance within the H30 and H30Rx Subclones of Escherichia coli Sequence Type 131 Compared with Other Fluoroquinolone-Resistant E. coli. Antimicrob Agents Chemother. 2015;59(8):4471-80. doi: 10.1128/AAC.00673-15 PMID: 25987621
25. Redgrave LS, Sutton SB, Webber MA, Piddock LJ. Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success. Trends Microbiol. 2014;22(8):438-45. doi: 10.1016/j.tim. 2014.04.007 PMID: 24842194
26. Morgan-Linnell SK, Zechiedrich L. Contributions of the combined effects of topoisomerase mutations toward fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother. 2007;51(11):4205-8. PMID: 17682104
27. Sand O, Gingras M, Beck N, Hall C, Trun N. Phenotypic characterization of overexpression or deletion of the Escherichia coli crcA, cspE and crcB genes. Microbiology. 2003;149(Pt 8):2107-17. PMID: 12904550
28. Edgar R, Bibi E. MdfA, an Escherichia coli multidrug resistance protein with an extraordinarily broad spectrum of drug recognition. J Bacteriol. 1997;179(7):2274-80. PMID: 9079913
29. Brill S, Falk OS, Schuldiner S. Transforming a drug/H+ antiporter into a polyamine importer by a single mutation. Proc Natl Acad Sci USA. 2012;109:16894-9. doi: 10.1073/pnas.1211831109 PMID: 23035252
30. Nishino K, Senda Y, Yamaguchi A. CRP regulator modulates multidrug resistance of Escherichia coli by repressing the mdtEF multidrug efflux genes. J Antibiot (Tokyo). 2008;61(3):120-7.
31. Federowicz S, Kim D, Ebrahim A, Lerman J, Nagarajan H, Cho BK, et al. Determining the control circuitry of redox metabolism at the genome-scale. PLoS Genet. 2014;10(4):e1004264. doi: 10.1371/journal.pgen. 1004264 PMID: 24699140
32. Inokuchi H, Ito R, Sekiguchi T, Sekiguchi M. Search for proteins required for accurate gene expression under oxidative stress: roles of guanylate kinase and RNA polymerase. J Biol Chem. 2013;288(46):32952-62. doi: 10.1074/jbc. M113.507772 PMID: 24097971
33. Pruteanu M, Baker TA. Proteolysis in the SOS response and metal homeostasis in Escherichia coli. Res Microbiol. 2009;160(9):677-83. doi: 10.1016/j.resmic.2009.08.012 PMID: 19747971
34. Gullberg E, Cao S, Berg OG, Ilback C, Sandegren L, Hughes D, et al. Selection of resistant bacteria at very low antibiotic concentrations. PLoS pathogens. 2011;7(7):e1002158. doi: 10.1371/journal.ppat. 1002158 PMID: 21811410
35. Davies J, Spiegelman GB, Yim G. The world of subinhibitory antibiotic concentrations. Curr Opin Microbiol. 2006;9(5):445-53. PMID: 16942902
36. Blair JM, Bavro VN, Ricci V, Modi N, Cacciotto P, Kleinekathfer U, et al. AcrB drug-binding pocket substitution confers clinically relevant resistance and altered substrate specificity. Proc Natl Acad Sci USA. 2015;112(11):3511-6. doi: 10.1073/pnas.1419939112 PMID: 25737552
37. Jellen-Ritter AS, Kern WV. Enhanced expression of the multidrug efflux pumps AcrAB and AcrEF associated with insertion element transposition in Escherichia coli mutants Selected with a fluoroquinolone. Antimicrob Agents Chemother. 2001;45(5):1467-72. PMID: 11302812
38. Rosner JL, Martin RG. Reduction of cellular stress by TolC-dependent efflux pumps in Escherichia coli indicated by BaeSR and CpxARP activation of spy in efflux mutants. J Bacteriol. 2013;195(5):1042-50. doi: 10.1128/JB.01996-12 PMID: 23264577
39. Blair JM, Smith HE, Ricci V, Lawler AJ, Thompson LJ, Piddock LJ. Expression of homologous RND efflux pump genes is dependent upon AcrB expression: implications for efflux and virulence inhibitor design. J Antimicrob Chemother. 2015;70(2):424-31. doi: 10.1093/jac/dku380 PMID: 25288678
40. Oethinger M, Kern WV, Jellen-Ritter AS, McMurry LM, Levy SB. Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump. Antimicrob Agents Chemother. 2000;44(1):10-3. PMID: 10602715
41. Du D, van Veen HW, Murakami S, Pos KM, Luisi BF. Structure, mechanism and cooperation of bacterial multidrug transporters. Curr Opin Struct Biol. 2015;33:76-91. doi: 10.1016/j.sbi.2015.07.015 PMID: 26282926
42. Li XZ, Plesiat P, Nikaido H. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clinical microbiology reviews. 2015;28(2):337-418. doi: 10.1128/CMR.00117-14 PMID: 25788514